Overview
CTSO market data
Price History
CTSO price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.13 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.32 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -48.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.35 – $1.19 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $23.3M · P/B 6.80 · P/S 0.62.
Company News
12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga · Aug 11, 2026, 9:06 PM
8-K filing — Cytosorbents Corp (CTSO)SEC EDGAR · Aug 7, 2026, 8:06 PM
CytoSorbents Q2 Adj. EPS $(0.07) Misses $(0.04) Estimate, Sales $9.633M Beat $9.346M EstimateBenzinga · Aug 6, 2026, 8:20 PM